homocysteine and Budd-Chiari Syndrome

homocysteine has been researched along with Budd-Chiari Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertino, G; Borzì, AM; Catania, VE; Drago, F; La Greca, G; Latteri, S; Malaguarnera, G; Malaguarnera, M1
Akarca, U; Balým, Z; Batur, Y; Can, C; Colak, Y; Ersoz, G; Gunsar, F; Karasu, Z; Oruc, N; Tokat, Y1
Günther, G; Heller, C; Junker, R; Kreuz, W; Kurnik, K; Nowak-Göttl, U; Schobess, R1

Other Studies

3 other study(ies) available for homocysteine and Budd-Chiari Syndrome

ArticleYear
Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis.
    Current molecular medicine, 2019, Volume: 19, Issue:7

    Topics: Adult; Aged; Biomarkers, Tumor; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Cholesterol, LDL; Female; Folic Acid; Homocysteine; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Vitamin B 12; Vitamin B 6

2019
Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome.
    European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:8

    Topics: Adult; Budd-Chiari Syndrome; Case-Control Studies; Factor V; Female; Homocysteine; Humans; Male; Middle Aged; Mutation; Prothrombin; Sex Factors; Turkey

2006
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
    British journal of haematology, 2000, Volume: 111, Issue:2

    Topics: Antibodies, Anticardiolipin; Antithrombins; Budd-Chiari Syndrome; Case-Control Studies; Confidence Intervals; Factor V; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Infant; Infant, Newborn; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Portal Vein; Prospective Studies; Protein C; Protein S; Prothrombin; Renal Veins; Venous Thrombosis

2000